Stoke Therapeutics grants new hires options for 70,950 shares at $32.13 each
STOK•New employee option grants
- Stoke Therapeutics granted stock options covering 70,950 shares to seven new employees, effective Aug. 17, 2026.
- The options carry an exercise price of $32.13 per share, matching the stock’s Aug. 17 close.
- Vesting runs over four years: 25% after one year, then monthly over the next 36 months, contingent on continued employment.
- The options have a 10-year term under the 2023 Inducement Plan.
